China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.97 +0.16 (+5.69%)
As of: Sep 30, 2026 · 9:59 AM EDT

China SXT Pharmaceuticals (SXTC) Convertible Debt (2019)

Updated

China SXT Pharmaceuticals' Convertible Debt was $818,230 in fiscal Q2 2020 (quarter ended Sep 30, 2019).

Analysis

China SXT Pharmaceuticals (SXTC) Convertible Debt (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 China SXT Pharmaceuticals 33,069.96 -85.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 818,230.00
API Access

China SXT Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=SXTC&period=max&api_key=YOUR_API_KEY